Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells

Virology

Volumn 314, Issue 2, 2003, Pages 510-520

  Horwitz, Marc S ^a   Ilic, Alex ^c   Fine, Cody ^b   Rodriguez, Enrique ^b   Sarvetnick, Nora ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c NONE

Author keywords

Coxsackievirus; Insulin dependent diabetes mellitus; T lymphocytes

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; COXSACKIE VIRUS; DIABETES MELLITUS; HYPERGLYCEMIA; IMMUNE RESPONSE; KNOCKOUT MOUSE; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS; PREDICTION; PRIORITY JOURNAL; REINFECTION; SUPERINFECTION; T LYMPHOCYTE; VIRUS DETECTION; VIRUS REPLICATION;

COXSACKIEVIRUS;

EID: 0141758304     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00462-8     Document Type: Article

References (61)

1. Andreoletti L., Hober D., Hober-Vandenberghe C., Belaich S., Vantyghem M.-C., Lefebvre J., Wattre P. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J. Med. Virol. 52:1997;121-127.
2. Andreoletti L., Hober D., Hober-Vandenberghe C., Fajardy I., Belaich S., Lambert V., Vantyghem M.C., Lefebvre J., Wattre P. Coxsackie B virus infection and beta cell autoantibodies in newly diagnosed IDDM adult patients. Clin. Diagn. Virol. 9:(2-3):1998;125-133.
3. Arnush M., Heitmeier M.R., Scarim A.L., Marino M.H., Manning P.T., Corbett J.A. IL-1 produced and released endogenously within human islets inhibits beta cell function. J. Clin. Invest. 102:(3):1998;516-526.
4. Beck M.A., Chapman N.M., McManus B.M., Mullican J.C., Tracy S. Secondary enterovirus infection in the murine model of myocarditis. Am. J. Pathol. 136:1990;669-681.
5. Berger M.M., See D.M., Aymard M., Lina B. Demonstration of persistent enterovirus in the pancreas of diabetic mice by in situ polymerase chain reaction. Clin. Diagn. Virol. 9:(2-3):1998;141-143.
6. Bureau J.F., Le Goff S., Thomas D., Parlow A.F., de la Torre J.C., Homann D., Brahic M., Oldstone M.B. Disruption of differentiated functions during viral infection in vivo. V. Mapping of a locus involved in susceptibility of mice to growth hormone deficiency due to persistent lymphocytic choriomeningitis virus infection. Virology. 281:(1):2001;61-66.
7. Cahill G.F. Jr., McDevitt H.O. Insulin-dependent diabetes mellitus the initial lesion . New Eng. J. Med. 304:(24):1981;1454-1465.
8. Campbell A.E., Loria R.M., Madge G.E. Coxsackievirus B cardiopathy and angiopathy in the hypercholesterolemic host. Atherosclerosis. 31:(3):1978;295-306.
9. Campbell I.L., Iscaro A., Harrison L.C. Interferon-γ and tumor necrosis factor-α cytotoxicity to murine islets of Langerhans . J. Immunol. 141:1988;2325-2329.
10. Chatterjee N., Hou J., Dockstader P., Charbonneau T. Coxsackievirus B4 infection alters thymic, splenic, and peripheral lymphocyte repertoire preceding onset of hyperglycemia in mice. J. Med. Virol. 38:(2):1992;124-131.
11. Chatterjee N., Nejman C., Gerling I. Purification and characterization of a strain of coxsackievirus B4 of human origin that induces diabetes in mice. J. Med. Virol. 26:(1):1988;57-69.
12. Chatterjee N.K., Gerling I., Nejman C. Pancreatic D-cell disorder in coxsackievirus B4-induced diabetic mice. Mol. Cell. Endocrinol. 67:(1):1989;39-45.
13. Chatterjee N.K., Haley T.M., Nejman C. Functional alterations in pancreatic beta cells as a factor in virus-induced hyperglycemia in mice. J. Biol. Chem. 260:(23):1985;12786-12791.
14. Chehadeh W., Weill J., Vantyghem M.C., Alm G., Lefebvre J., Wattre P., Hober D. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus relationship with coxsackievirus B infection . J. Infect. Dis. 181:(6):2000;1929-1939.
15. Clements G., Galbraith D., Taylor K. Coxsackie B virus infection and onset of childhood diabetes. Lancet. 346:1995;221-223.
16. Flodstrom M., Maday A., Balakrishna D., Cleary M.M., Yoshimura A., Sarvetnick N. Target cell defense prevents the development of diabetes after viral infection. Nat. Immunol. 3:(4):2002;373-382.
17. Gepts W. Pathological anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 14:1965;619-633.
18. Gepts W., Int Veld P. Islet morphologic changes. Diabetes/Metab. Rev. 3:(4):1987;859-872.
19. Gepts W., Lecompte P. The pancreatic islets in diabetes. J. Med. 70:1981;105-115.
20. Gerling I., Chatterjee N., Nejman C. Coxsackievirus B4-induced development of antibodies to 64,000-Mr islet autoantigen and hyperglycemia in mice. Autoimmunity. 10:(1):1991;49-56.
21. Gerling I., Nejman C., Chatterjee N. Effect of coxsackievirus B4 infection in mice on expression of 64,000-Mr autoantigen and glucose sensitivity of islets before development of hyperglycemia. Diabetes. 37:(10):1988;1419-1425.
22. Girn J., Kavoosi M., Chantler J. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. J. Gen. Virol. 83:2002;351-358.
23. Hafler D., Fos D., Benjamin M., Blue M., Weiner H. Secondary immune amplification following live poliovirus immunization in humans. Clin. Immunol. Immunopathol. 44:1987;321-328.
24. Hartig P., Webb S. Heterogeneity of a human isolate of Coxsackie B4 biological differences . J. Infect. 6:(1):1983;43-48.
25. Hoet J.J., Reusens B., Remacle C. Lessons from the pathology of the diabetic pancreas. Horm. Metab. Res. 19:(11):1987;523-525.
26. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Coxsackie virus-induced diabetes initiation by bystander damage and not molecular mimicry . Nat. Med. 4:(7):1998;781-785.
27. Horwitz M.S., Krahl T., Fine C., Lee J., Sarvetnick N. Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon. J. Virol. 73:(3):1999;1756-1766.
28. Hou J., Said C., Franchi D., Dockstader P., Chatterjee N. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients. Diabetes. 43:(10):1994;1260-1266.
29. Hou J., Sheikh S., Martin D., Chatterjee N. Coxsackievirus B4 alters pancreatic glutamate decarboxylase expression in mice soon after infection. J. Autoimmun. 6:(5):1993;529-542.
30. Juhela S., Hyoty H., Roivainen M., Harkonen T., Putto-Laurila A., Simell O., Ilonen J. T-cell responses to enterovirus antigens in children with type 1 diabetes. Diabetes. 49:(8):2000;1301-1308.
31. Kash S.F., Condie B.G., Baekkeskov S. Glutamate decarboxylase and GABA in pancreatic islets lessons from knock-out mice . Horm. Metab. Res. 31:1999;340-344.
32. Kaufman D., Clare-Salzler M., Tian J., Forsthuber T., Ting G., Robinson P., Atkinson M., Sercarz E., Tobin A., Lehmann P. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:(6450):1993;69-72.
33. Kaufman D., Erlander M., Clare-Salzler M., Atkinson M., Maclaren N., Tobin A. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 89:(1):1992;283-292.
34. Klemetti P., Hyoty H., Roivainen M., Ilonen J., Savola K., Knip M., Akerblom H.K., Vaarala O. Relation between T-cell responses to glutamate decarboxylase and coxsackievirus B4 in patients with insulin-dependent diabetes mellitus. J. Clin. Virol. 14:(2):1999;95-105.
35. Koh D.R., Fung-Leung W.P., Ho A., Gray D., Acha-Orbea H., Mak T.W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science. 256:(5060):1992;1210-1213.
36. Lansdown A.B., Coid C.R. Pathological changes in pregnant mice infected with Coxsackie B3 virus as a possible cause of retarded foetal development. Br. J. Exp. Pathol. 55:(2):1974;101-109.
37. Lonnrot M., Korpela K., Knip M., Ilonen J., Simell O., Korhonen S., Savola K., Muona P., Simell T., Koskela P., Hyoty H. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort the Finnish Diabetes Prediction and Prevention Study . Diabetes. 49:(8):2000;1314-1318.
38. Lonnrot M., Salminen K., Knip M., Savola K., Kulmala P., Leinikki P., Hyypia T., Akerblom H.K., Hyoty H. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes a prospective study. Childhood Diabetes in Finland (DiMe) Study Group . J. Med. Virol. 61:(2):2000;214-220.
39. Loria R.M., Kibrick S., Broitman S.A. Peroral infection with group B coxsackievirus in the adult mouse protective functions of the gut . J. Infect. Dis. 130:(5):1974;539-543.
40. Lyles D.S. Cytopathogenesis and inhibition of host gene expression by RNA viruses. Microbiol. Mol. Biol. Rev. 64:(4):2000;709-724.
41. Mandrup-Poulsen T. Cytokine-mediated beta-cell destruction - the molecular effector mechanism causing IDDM. J. Autoimmun. 3:(Suppl 1):1990;121-122.
42. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia. 39:(9):1996;1005-1029.
43. McRae B.L., Vanderburg C.L., Dal Canto M., Miller S. Functional evidence for epitope spreading in the releasing pathology of MS. J. Exp. Med. 182:1995;75-85.
44. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., Katz-Levy Y., Carrizosa A., Kim B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:(10):1997;1-4.
45. Nairn C., Galbraith D.N., Taylor K.W., Clements G.B. Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus. Diabetes Med. 16:(6):1999;509-513.
46. Roivainen M., Knip M., Hyoty H., Kulmala P., Hiltunen M., Vahasalo P., Hovi T., Akerblom H. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. J. Med. Virol. 56:(1):1998;74-78.
47. Sadeharju K., Lonnrot M., Kimpimaki T., Savola K., Erkkila S., Kalliokoski T., Savolainen P., Koskela P., Ilonen J., Simell O., Knip M., Hyoty H. Enterovirus antibody levels during the first two years of life in prediabetic autoantibody-positive children. Diabetologia. 44:(7):2001;818-823.
48. Sarugeri E., Dozio N., Meschi F., Pastore M.R., Bonifacio E. T cell responses to type 1 diabetes related peptides sharing homologous regions. J. Mol. Med. 79:(4):2001;213-220.
49. See D., Tilles J. Pathogenesis of virus-induced diabetes in mice. J. Infect. Dis. 171:(5):1995;1131-1138.
50. Selin L., Varga S., Wong I., Welsh R. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188:(9):1998;1705-1715.
51. Tam P.E., Messner R.P. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution . J. Virol. 73:(12):1999;10113-10121.
52. Tisch R., Yang X., Singer S., Liblau R., Fugger L., McDevitt H. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:(6450):1993;72-75.
53. Tough D., Borrow P., Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science. 272:1996;1947-1950.
54. Varela-Calvino R., Sgarbi G., Wedderburn L.R., Dayan C.M., Tremble J., Peakman M. T cell activation by coxsackievirus B4 antigens in type 1 diabetes mellitus evidence for selective TCR Vbeta usage without superantigenic activity . J. Immunol. 167:(6):2001;3513-3520.
55. Vreugdenhil G.R., Batstra M.R., Aanstoot H.J., Melchers W.J., Galama J.M. Analysis of antibody responses against coxsackie virus B4 protein 2C and the diabetes autoantigen GAD(65). J. Med. Virol. 59:(2):1999;256-261.
56. Walzl G., Tafuro S., Moss P., Openshaw P.J., Hussell T. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J. Exp. Med. 192:(9):2000;1317-1326.
57. Webb S., Loria R., Madge G., Kibrick S. Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. J. Exp. Med. 143:(5):1976;1239-1248.
58. Welsh R.M., McNally J.M., Brehm M.A., Selin L.K. Consequences of cross-reactive and bystander CTL responses during viral infections. Virology. 270:(1):2000;4-8.
59. Wogensen L.D., Reimers J., Nerup J., Kolb-Bachofen V., Kroncke K.D., Almdal T., Mandrup-Poulsen T. Repetitive in vivo treatment with human recombinant interleukin-1 beta modifies beta-cell function in normal rats. Diabetologia. 35:(4):1992;331-339.
60. Yoon J., Onodera T., Notkins A. Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J. Exp. Med. 148:(4):1978;1068-1080.
61. Yoon J.W., Yoon C.S., Lim H.W., Huang Q.Q., Kang Y., Pyun K.H., Hirasawa K., Sherwin R.S., Jun H.S. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science. 284:1999;1183-1187.